GENEVA, April 1 -- HLB PHARMACEUTICAL CO., LTD. (27, Gyeonggang-roNamyangju-siGyeonggi-do 12244), 에이치엘비제약 주식회사 (경기도남양주시경강로 27), HLB CELL CO.,LTD (8Fl., Dongtan M tower, 51-9, Dongtancheomdansaneop 1-roHwaseong-siGyeonggi-do 18469), 에이치엘비셀 주식회사 (경기도화성시동탄첨단산업1로 51-9, 동탄엠타워 8층) filed a patent application (PCT/KR2024/014126) for "INJECTABLE COMPOSITION COMPRISING CROSSLINKED HYALURONIC ACID HYDROGEL A...